EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer

Not Applicable

Completed

Conditions: Penile Carcinoma
Lymphadenopathy
Extramammary Paget's Disease
Scrotal Carcinoma
Vulvar Cancer
Skin Cancer
Melanoma
Merkel Cell Carcinoma
Anal Cancer
Squamous Cell Carcinoma

Interventions: Procedure: Videoscopic procedure
Procedure: Open, traditional approach

First Posted Date: 2012-02-06

Last Posted Date: 2015-05-06

Lead Sponsor: Emory University

Target Recruit Count: 29

Registration Number: NCT01526486

Locations: 🇺🇸
Emory University Hospital-Winship Cancer Institute, Atlanta, Georgia, United States

A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction

Phase 4

Completed

Conditions: Temporomandibular Joint Dysfunction
Arthrocentesis
Pain

Interventions: Drug: Corticosteroid
Drug: Lactated Ringers
Drug: Hyaluronic acid

First Posted Date: 2012-02-02

Last Posted Date: 2017-05-05

Lead Sponsor: Emory University

Target Recruit Count: 102

Registration Number: NCT01524913

Locations: 🇺🇸
University of Cinncinati, Cinncinati, Ohio, United States
🇺🇸
University California Los Angeles, Los Angeles, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 2 locations

Effects of Atomoxetine in Mild Cognitive Impairment

Phase 2

Completed

Conditions: Mild Cognitive Impairment

Interventions: Drug: Atomoxetine
Drug: Placebo

First Posted Date: 2012-01-31

Last Posted Date: 2019-07-23

Lead Sponsor: Emory University

Target Recruit Count: 39

Registration Number: NCT01522404

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States

Investigation of Endothelium in Saphenous Vein Grafts

Not Applicable

Completed

Conditions: Endothelial Function of Saphenous Vein Grafts

Interventions: Other: Use of Maquet Vasoshield Pressure-limiting syringe on SVG
Other: Use of non-regulated syringe on SVG

First Posted Date: 2012-01-18

Last Posted Date: 2013-10-01

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT01510821

Locations: 🇺🇸
Cardiothoracic Surgery Research Laboratory, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Immune Memory After Papillomavirus Vaccination

Completed

Conditions: Healthy Volunteers

Interventions: Drug: quadrivalent HPV vaccine

First Posted Date: 2012-01-06

Last Posted Date: 2015-07-21

Lead Sponsor: Emory University

Target Recruit Count: 203

Registration Number: NCT01505049

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule

Phase 1

Completed

Conditions: Lung Cancer

Interventions: Drug: 18F-FACBC Radiotracer

First Posted Date: 2012-01-02

Last Posted Date: 2013-11-19

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT01502670

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery

Not Applicable

Completed

Conditions: Stroke

Interventions: Procedure: No aortic clamping
Procedure: partial occluding clamp
Procedure: cross clamp and partial occluding clamp
Procedure: single cross clamp

First Posted Date: 2012-01-02

Last Posted Date: 2017-01-24

Lead Sponsor: Emory University

Target Recruit Count: 193

Registration Number: NCT01502683

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Phase 2

Terminated

Conditions: Breast Neoplasms
Breast Tumors
Breast Cancer
Tumors, Breast
Cancer of the Breast
Neoplasms, Breast

Interventions: Drug: Eribulin
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: Pegfilgrastim

First Posted Date: 2011-12-23

Last Posted Date: 2016-10-03

Lead Sponsor: Emory University

Target Recruit Count: 7

Registration Number: NCT01498588

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States

and more 1 locations

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Phase 2

Terminated

Conditions: Cutaneous Lupus Erythematosus

Interventions: Dietary Supplement: vitamin D

First Posted Date: 2011-12-23

Last Posted Date: 2013-11-20

Lead Sponsor: Emory University

Target Recruit Count: 3

Registration Number: NCT01498406

Locations: 🇺🇸
Emory Dermatology Clinics, Atlanta, Georgia, United States

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Phase 1

Completed

Conditions: Neoplasms, Esophageal
Esophageal Cancer

Interventions: Drug: RAD001
Drug: XELOX
Drug: Carboplatin
Radiation: Radiation

First Posted Date: 2011-12-13

Last Posted Date: 2019-03-15

Lead Sponsor: Emory University

Target Recruit Count: 17

Registration Number: NCT01490749

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy